Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,177–1,184 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Cadrenal Therapeutics Inc. Tecarfarin - (ACTOR-AF) End-stage renal disease and AFib not currently treated with chronic oral anticoagulation. Phase 3 Looking for Funding Oral Cardiology
CalciMedica Inc. GB-102 - (ALTISSIMO) Wet age-related macular degeneration Phase 2b Clinical Hold Intravitreal injection Opthalmic
CalciMedica Inc. Auxora - (KOURAGE) Acute kidney injury (AKI) with associated acute hypoxemic respiratory failure (AHRF) Phase 2 Trial Discontinued Intravenous Respiratory
CalciMedica Inc. GB-102 Wet age-related macular degeneration (AMD) Phase 2 Clinical Hold Intravitreal injection Opthalmic
CalciMedica Inc. GB-102 Diabetic macular edema (DME) Phase 2b Clinical Hold Intravitreal injection Opthalmic
CalciMedica Inc. Auxora - (CARPO) Acute Pancreatitis Phase 3 Trial Planned Intravenous Gastroenterology
Calithera Biosciences Inc. Telaglenastat (CB-839) - (KEAPSAKE) Non-small cell lung cancer (NSCLC) patients with genetic mutation NRF2/KEAP1 Phase 2 Oral Oncology
Calithera Biosciences Inc. Sapanisertib (CB-228) NRF2-mutated squamous small cell lung cancer (NSCLC) Phase 2 Oral Oncology
1…146147148149150…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.